Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
4 hedge funds and large institutions have $138K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
250% more call options, than puts
Call options by funds: $21K | Put options by funds: $6K
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less funds holding
Funds holding: 5 → 4 (-1)
57% less capital invested
Capital invested by funds: $319K → $138K (-$181K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$125K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$50.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$311K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$351 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $134K | +$125K | +183,600 | New |
|
2
Twin Tree Management
Dallas,
Texas
| $4K | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $336 | +$50.6K | +74,354 | +19% |
|
|
4
Fidelity Investments
Boston,
Massachusetts
| – | -$311K | -375,000 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$351 | -516 | -71% |
|
SGYPW Hedge Fund Activity: Q4 2014 in Review
4 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q4 2014, worth a combined $138K — down 57% from $319K a quarter earlier.
Fund positioning in SGYPW was balanced in Q4 2014: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $125K. The largest seller was Fidelity Investments, exiting entirely with an estimated $311K sold.
- 4 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q4 2014, down from 5 in Q3 2014.
- Funds reported $138K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q4 2014, down 57% quarter-over-quarter.
- 1 fund opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q4 2014 and 1 closed out, a net change of 0 holders.
- The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q4 2014 was Deutsche Bank, an estimated $125K added.
- The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q4 2014 was Fidelity Investments, an estimated $311K sold.
Based on aggregated 13F filings for Q4 2014.